Sobre o Autor 0 Comentrios
FAQs Who should consider GLP-1 therapy during menopause
CJC-1295 dosing approaches: CJC-1295 without DAC (Mod GRF 1-29): Dose: 100-200mcg per injection Frequency: 2-3x daily with meals or before bed Works synergistically with Ipamorelin/GHRP Short half-life, requires frequent dosing CJC-1295 with DAC: Dose: 1-2mg per week total Frequency: 2-3 injections weekly (or single weekly) Long-acting, elevated GH for days More convenient than without DAC Example: 5mg vial + 2ml water = 2,500mcg/ml 1mg dose (1,000mcg) = draw 0.40ml 100mcg dose (without DAC) = draw 0.04ml Most people use CJC-1295 WITH DAC for convenience
By mimicking or enhancing the effects of these hormones, Semaglutide and Tirzepatide help curb cravings, improve insulin sensitivity, and promote significant fat loss, making them highly effective tools for sustainable weight loss and metabolic health improvement
Lateral hypothalamic NMDA receptors and glutamate as physiological mediators of eating and weight control
Study Data include pleasant taste, easy and quick absorption, a sense of overall well-being and changes in severity of symptoms and alleviation of discomfort in all stages of life